JAMA Editors' Summary

Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more

Dec 5, 2023
Ask episode
Chapters
Transcript
Episode notes